Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Jin Ho | - |
dc.contributor.author | Jeong, Jae Uk | - |
dc.contributor.author | Lee, Jong Hoon | - |
dc.contributor.author | Kim, Sung Hwan | - |
dc.contributor.author | Cho, Hyeon Min | - |
dc.contributor.author | Um, Jun Won | - |
dc.contributor.author | Jang, Hong Seok | - |
dc.date.accessioned | 2021-09-03T02:36:04Z | - |
dc.date.available | 2021-09-03T02:36:04Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 2234-1900 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/82455 | - |
dc.description.abstract | Purpose: Whether preoperative chemoradiotherapy (CRT) is better than postoperative CRT in oncologic outcome and toxicity is contentious in prospective randomized clinical trials. We systematically analyze and compare the treatment result, toxicity, and sphincter preservation rate between preoperative CRT and postoperative CRT in stage II-III rectal cancer. Materials and Methods: We searched Medline, Embase, and Cochrane Library from 1990 to 2014 for relevant trials. Only phase III randomized studies performing CRT and curative surgery were selected and the data were extracted. Meta-analysis was used to pool oncologic outcome and toxicity data across studies. Results: Three randomized phase III trials were finally identified. The meta-analysis results showed significantly lower 5-year locoregional recurrence rate in the preoperative-CRT group than in the postoperative-CRT group (hazard ratio, 0.59; 95% confidence interval, 0.41-0.84; p = 0.004). The 5-year distant recurrence rate (p = 0.55), relapse-free survival (p = 0.14), and overall survival (p = 0.22) showed no significant difference between two groups. Acute toxicity was significantly lower in the preoperative-CRT group than in the postoperative-CRT group (p < 0.001). However, there was no significant difference between two groups in perioperative and chronic complications (p = 0.53). The sphincter-saving rate was not significantly different between two groups (p = 0.24). The conversion rate from abdominoperineal resection to low anterior resection in low rectal cancer was significantly higher in the preoperative-CRT group than in the postoperative-CRT group (p < 0.001). Conclusions: As compared to postoperative CRT, preoperative CRT improves only locoregional control, not distant control and survival, with similar chronic toxicity and sphincter preservation rate in rectal cancer patients. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC THERAPEUTIC RADIOLOGY & ONCOLOGY | - |
dc.subject | TOTAL MESORECTAL EXCISION | - |
dc.subject | CURATIVE SURGERY | - |
dc.subject | FOLLOW-UP | - |
dc.subject | RADIOTHERAPY | - |
dc.subject | FLUOROURACIL | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | MULTICENTER | - |
dc.subject | CARCINOMA | - |
dc.subject | THERAPY | - |
dc.title | Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Um, Jun Won | - |
dc.identifier.doi | 10.3857/roj.2017.00059 | - |
dc.identifier.wosid | 000413844600002 | - |
dc.identifier.bibliographicCitation | RADIATION ONCOLOGY JOURNAL, v.35, no.3, pp.198 - 207 | - |
dc.relation.isPartOf | RADIATION ONCOLOGY JOURNAL | - |
dc.citation.title | RADIATION ONCOLOGY JOURNAL | - |
dc.citation.volume | 35 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 198 | - |
dc.citation.endPage | 207 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002267187 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | TOTAL MESORECTAL EXCISION | - |
dc.subject.keywordPlus | CURATIVE SURGERY | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | RADIOTHERAPY | - |
dc.subject.keywordPlus | FLUOROURACIL | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | MULTICENTER | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | Chemoradiotherapy | - |
dc.subject.keywordAuthor | Preoperative | - |
dc.subject.keywordAuthor | Postoperative | - |
dc.subject.keywordAuthor | Rectal cancer | - |
dc.subject.keywordAuthor | Surgery | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.